CB3: 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID
CB3 is a Ligand Of Interest in 6AOG designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
6AOG_CB3_B_703 | 7% | 18% | 0.4 | 0.854 | 1.15 | 2.32 | 3 | 8 | 3 | 0 | 100% | 0.5 |
6AOG_CB3_A_703 | 7% | 17% | 0.393 | 0.842 | 1.17 | 2.38 | 3 | 9 | 0 | 0 | 100% | 0.5 |
4EIL_CB3_G_702 | 76% | 9% | 0.105 | 0.941 | 1.96 | 2.43 | 8 | 13 | 1 | 0 | 100% | 1 |
6AOH_CB3_B_703 | 21% | 17% | 0.297 | 0.91 | 1.18 | 2.4 | 3 | 8 | 1 | 0 | 100% | 0.5 |
6N1T_CB3_B_703 | 21% | 17% | 0.297 | 0.91 | 1.18 | 2.4 | 3 | 8 | 1 | 0 | 100% | 0.5 |
6N1S_CB3_A_703 | 17% | 33% | 0.303 | 0.88 | 0.76 | 1.88 | 1 | 5 | 0 | 0 | 100% | 0.5 |
6AOI_CB3_B_703 | 10% | 17% | 0.362 | 0.869 | 1.16 | 2.39 | 2 | 10 | 1 | 0 | 100% | 0.5 |
6NNR_CB3_B_302 | 93% | 19% | 0.076 | 0.97 | 1.19 | 2.25 | 3 | 8 | 0 | 0 | 100% | 1 |
2AAZ_CB3_E_2551 | 92% | 5% | 0.081 | 0.973 | 2.5 | 2.75 | 16 | 15 | 0 | 0 | 100% | 0.25 |
4GEV_CB3_B_802 | 87% | 25% | 0.081 | 0.954 | 1.15 | 1.91 | 3 | 10 | 0 | 0 | 100% | 1 |
2FTO_CB3_X_266 | 82% | 17% | 0.087 | 0.943 | 1.58 | 2 | 6 | 6 | 1 | 0 | 100% | 1 |
6CDZ_CB3_A_701 | 53% | 20% | 0.16 | 0.922 | 1.31 | 2.06 | 3 | 11 | 0 | 0 | 100% | 1 |